What are prostate cancer risk factors? What are the early symptoms? What are the latest treatment advances? Twitter users had questions – and City of Hope physicians had answers during today’s TweetChat.
Offering their expertise were Cy Stein, M.D., Ph.D., City of Hope's Arthur & Rosalie Kaplan Chair in Medical Oncology, and Mark Kawachi, M.D., associate clinical professor in City of Hope's Division of Urology and Urologic Oncology. They discussed prostate cancer research, screening, treatment and much more under the hashtag #ProstateChat.
You can read the full chat below.
For more answers, attend our Ask the Experts session on Sept. 17 from 6:30 p.m. to 7 p.m. Titled "Prostate Cancer: What Every Man (and Woman) Should Know," the session will sort through conflicting information about the detection and treatment of prostate cancer by providing the latest information and answers to your questions. It will also address state-of-the-art robotic-assisted laparoscopic surgery.
Sign up online here or call 800-535-1390, ext. 65669. Above, Kawachi elaborates on the management of side effects. (Only so much can be explained in a Tweet.) Here, he discusses prostate cancer screening.
Denise Heady contributed to this report.